MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas

. 2013 Mar ; 112 (1) : 1-8. [epub] 20130111

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid23307326

Meningiomas represent one of the most common types of primary intracranial tumours. However, the specific molecular mechanisms underlying their pathogenesis remain uncertain. Loss of chromosomes 22q, 1p, and 14q have been implicated in most meningiomas. Inactivation of the NF2 gene at 22q12 has been identified as an early event in their pathogenesis, whereas abnormalities of chromosome 14 have been reported in higher-grade as well as recurrent tumours. It has long been supposed that chromosome 14q32 contains a tumour suppressor gene. However, the identity of the potential 14q32 tumour suppressor remained elusive until the Maternally Expressed Gene 3 (MEG3) was recently suggested as an ideal candidate. MEG3 is an imprinted gene located at 14q32 that encodes a non-coding RNA (ncRNA). In meningiomas, loss of MEG3 expression, its genomic DNA deletion and degree of promoter methylation have been found to be associated with aggressive tumour growth. These findings indicate that MEG3 may have a significant role as a novel long noncoding RNA tumour suppressor in meningiomas.

Zobrazit více v PubMed

Curr Opin Oncol. 1995 Jan;7(1):76-82 PubMed

Cancer Res. 2003 Sep 15;63(18):5703-6 PubMed

Genome Res. 2000 Nov;10(11):1711-8 PubMed

Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R121-32 PubMed

Mol Cell Endocrinol. 2010 Sep 15;326(1-2):40-7 PubMed

Genes Dev. 2006 Jan 1;20(1):16-21 PubMed

Cancer Res. 2005 Jan 1;65(1):26-33 PubMed

Clin Cancer Res. 1999 May;5(5):1231-40 PubMed

Am J Physiol Cell Physiol. 2004 May;286(5):C1089-99 PubMed

Oncogene. 1997 Feb 6;14(5):611-6 PubMed

Dev Dyn. 1998 Jun;212(2):214-28 PubMed

Science. 1998 May 15;280(5366):1035-6 PubMed

Mol Cell Biol. 1998 Feb;18(2):753-61 PubMed

Blood. 2001 Jul 15;98(2):422-7 PubMed

Leuk Res. 2010 Feb;34(2):148-53 PubMed

J Neurosurg. 1985 Jan;62(1):18-24 PubMed

Cell. 2004 Nov 24;119(5):591-602 PubMed

Cancer Res. 2002 Feb 15;62(4):1222-30 PubMed

Clin Lymphoma Myeloma. 2008 Jun;8(3):171-5 PubMed

Hum Mol Genet. 2002 Jun 15;11(13):1527-38 PubMed

Hum Mol Genet. 2002 Jan 1;11(1):77-86 PubMed

Oncogene. 2006 Aug 28;25(38):5220-7 PubMed

J Biol Chem. 2000 Jun 30;275(26):20127-35 PubMed

Acta Neuropathol. 2007 Aug;114(2):97-109 PubMed

Mol Cell Biochem. 2007 Aug;302(1-2):67-77 PubMed

Nucleic Acids Res. 1998 Aug 1;26(15):3453-9 PubMed

Oncogene. 1993 Sep;8(9):2353-60 PubMed

Nat Genet. 2003 Sep;35(1):97-102 PubMed

Br J Cancer. 2005 Apr 25;92(8):1574-80 PubMed

Brain Res. 2008 Jan 10;1188:25-34 PubMed

Endocrinology. 2010 Jun;151(6):2443-52 PubMed

Cancer Res. 2010 Mar 15;70(6):2350-8 PubMed

J Neurochem. 2000 Dec;75(6):2227-40 PubMed

Neurosurgery. 2009 Jan;64(1):56-60; discussion 60 PubMed

Surg Neurol. 1986 Nov;26(5):461-9 PubMed

EMBO J. 1998 May 1;17(9):2513-25 PubMed

Int J Biochem Cell Biol. 2006;38(10):1808-20 PubMed

J Biol Chem. 2007 Aug 24;282(34):24731-42 PubMed

Mutat Res. 2011 Feb 10;707(1-2):24-33 PubMed

Oncogene. 2001 Jul 5;20(30):4041-9 PubMed

Endocrinology. 2010 Mar;151(3):939-47 PubMed

Am J Pathol. 2004 Jun;164(6):2259-67 PubMed

Cell. 1995 May 5;81(3):323-30 PubMed

Mol Cancer Res. 2004 Jan;2(1):1-8 PubMed

J Cell Biochem. 2012 Jun;113(6):1868-74 PubMed

Oncogene. 2002 Jun 20;21(27):4212-9 PubMed

Int J Cancer. 2011 Aug 15;129(4):773-9 PubMed

Fertil Steril. 2002 Jul;78(1):114-21 PubMed

Semin Cancer Biol. 2003 Feb;13(1):49-58 PubMed

Nat Med. 1996 Aug;2(8):912-7 PubMed

J Clin Oncol. 2005 Jan 1;23(1):154-64 PubMed

Genome Res. 2001 May;11(5):850-62 PubMed

J Biol Chem. 2003 May 23;278(21):19358-66 PubMed

Proc Natl Acad Sci U S A. 2008 May 13;105(19):7004-9 PubMed

Int J Cancer. 2001 Oct 15;94(2):218-21 PubMed

Genes Dev. 1993 Jul;7(7A):1126-32 PubMed

Cancer. 2000 Sep 1;89(5):1102-10 PubMed

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 PubMed

J Neurooncol. 2001 Dec;55(3):149-58 PubMed

J Clin Endocrinol Metab. 2003 Nov;88(11):5119-26 PubMed

J Neuropathol Exp Neurol. 2001 Jun;60(6):628-36 PubMed

J Clin Endocrinol Metab. 2008 Oct;93(10):4119-25 PubMed

J Clin Endocrinol Metab. 2005 Apr;90(4):2179-86 PubMed

Curr Opin Cell Biol. 2003 Apr;15(2):164-71 PubMed

Cancer Res. 1995 Oct 15;55(20):4696-701 PubMed

Trends Cell Biol. 2002 Jun;12(6):258-66 PubMed

Cell Death Differ. 2006 Jun;13(6):927-34 PubMed

Cancer Cell. 2002 Jul;2(1):9-15 PubMed

Genes Cells. 2000 Mar;5(3):211-20 PubMed

Nature. 1997 May 15;387(6630):296-9 PubMed

Nature. 2000 Nov 16;408(6810):307-10 PubMed

Science. 1996 Dec 6;274(5293):1672-7 PubMed

Nature. 1992 Jul 2;358(6381):80-3 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...